Design and synthesis of analogues of RA-VII-an antitumor bicyclic hexapeptide from Rubiae radix
© 2021. The Author(s)..
The 14-membered cycloisodityrosine is the core structure of RA-series antitumor bicyclic peptides obtained from Rubia plants (Rubiaceae). In this study, an efficient method for the synthesis of cycloisodityrosines from commercially available L-tyrosine derivatives was developed. Using synthetic cycloisodityrosines and cycloisodityrosines with modified structures, several RA-VII analogues were designed and synthesized to explore structure-activity relationships of the cycloisodityrosine moiety of the RA-series peptides, and newly isolated natural peptides were synthesized to establish their structures.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:75 |
---|---|
Enthalten in: |
Journal of natural medicines - 75(2021), 4 vom: 09. Sept., Seite 752-761 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Hitotsuyanagi, Yukio [VerfasserIn] |
---|
Links: |
---|
Themen: |
Analogue synthesis |
---|
Anmerkungen: |
Date Completed 25.11.2021 Date Revised 18.02.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s11418-021-01542-w |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM327907428 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM327907428 | ||
003 | DE-627 | ||
005 | 20231225201822.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s11418-021-01542-w |2 doi | |
028 | 5 | 2 | |a pubmed24n1092.xml |
035 | |a (DE-627)NLM327907428 | ||
035 | |a (NLM)34244894 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Hitotsuyanagi, Yukio |e verfasserin |4 aut | |
245 | 1 | 0 | |a Design and synthesis of analogues of RA-VII-an antitumor bicyclic hexapeptide from Rubiae radix |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.11.2021 | ||
500 | |a Date Revised 18.02.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2021. The Author(s). | ||
520 | |a The 14-membered cycloisodityrosine is the core structure of RA-series antitumor bicyclic peptides obtained from Rubia plants (Rubiaceae). In this study, an efficient method for the synthesis of cycloisodityrosines from commercially available L-tyrosine derivatives was developed. Using synthetic cycloisodityrosines and cycloisodityrosines with modified structures, several RA-VII analogues were designed and synthesized to explore structure-activity relationships of the cycloisodityrosine moiety of the RA-series peptides, and newly isolated natural peptides were synthesized to establish their structures | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Analogue synthesis | |
650 | 4 | |a Cyclic peptide | |
650 | 4 | |a Cycloisodityrosine | |
650 | 4 | |a Cytotoxic activity | |
650 | 4 | |a Rubia species | |
650 | 4 | |a Rubiaceae | |
650 | 7 | |a Peptides, Cyclic |2 NLM | |
650 | 7 | |a RA VII |2 NLM | |
650 | 7 | |a HVM25O0351 |2 NLM | |
773 | 0 | 8 | |i Enthalten in |t Journal of natural medicines |d 2006 |g 75(2021), 4 vom: 09. Sept., Seite 752-761 |w (DE-627)NLM178740268 |x 1861-0293 |7 nnns |
773 | 1 | 8 | |g volume:75 |g year:2021 |g number:4 |g day:09 |g month:09 |g pages:752-761 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s11418-021-01542-w |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 75 |j 2021 |e 4 |b 09 |c 09 |h 752-761 |